Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

ImmVira Posts Positive Data from Trial of Oncolytic Virus Injection for Melanoma

publication date: Feb 9, 2023

Shenzhen ImmVira reported its first intratumoral injected oncolytic virus product, MVR-T3011 IT, was effective in early tests, raising Progression-Free Survival in melanoma patients to 12.9 months. The patients had previously failed another treatment. MVR-T3011 is a 3-in-1 oncolytic herpes simplex virus that aims to achieve the best profile of attenuated HSV-1 with high levels of replication in tumor cells while causing only highly restricted replication in normal cells. The product includes two well-validated exogenous genes, PD-1 antibody and IL-12, to enhance the immune responses in the tumor microenvironment. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here